Skip to main content
. 2021 Feb 2;77(8):1089–1094. doi: 10.1007/s00228-021-03087-z

Fig. 2.

Fig. 2

Forest plot showing the a pooled odds ratio of all-cause mortality and b pooled hazard ratio of requirement for mechanical ventilation and/or all-cause mortality between patients with COVID-19 treated with tocilizumab and those not treated with tocilizumab